Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
Clorox
CLX
$12.8B
| $621K | ﹤0.01% |
4,175
-56,967
| -93% | -$7.75M |
|
|
CPE
5177
CALL
DELISTED
Callon Petroleum Company
CPE
| $621K | ﹤0.01% |
5,110
+1,650
| +48% | +$183K |
|
5178
CALL
Saic
SAIC
$5.36B
| $620K | ﹤0.01% |
8,100
-4,900
| -38% | -$354K |
|
5179
Eversource Energy
ES
$27.2B
| $619K | ﹤0.01% |
9,799
-146,986
| -94% | -$9.29M |
|
5180
PUT
OneMain Financial
OMF
$7.56B
| $619K | ﹤0.01% |
+23,800
| New | +$657K |
|
|
SFUN
5181
PUT
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $619K | ﹤0.01% |
2,220
-428
| -16% | -$96.5K |
|
5182
CALL
ResMed
RMD
$32.4B
| $618K | ﹤0.01% |
7,300
+1,300
| +22% | +$107K |
|
5183
CALL
Tenaris
TS
$27B
| $618K | ﹤0.01% |
19,400
-10,000
| -34% | -$290K |
|
5184
Cardinal Health
CAH
$54.7B
| $617K | ﹤0.01% |
10,065
-184,824
| -95% | -$11.4M |
|
|
CMD
5185
CALL
DELISTED
Cantel Medical Corporation
CMD
| $617K | ﹤0.01% |
+6,000
| New | +$598K |
|
|
SFLY
5186
PUT
DELISTED
Shutterfly, Inc.
SFLY
| $617K | ﹤0.01% |
12,400
+6,800
| +121% | +$308K |
|
5187
CALL
Ternium
TX
$10.6B
| $616K | ﹤0.01% |
19,500
+3,500
| +22% | +$105K |
|
5188
CALL
United Natural Foods
UNFI
$2.93B
| $616K | ﹤0.01% |
12,500
-1,300
| -9% | -$56.8K |
|
|
PFC
5189
DELISTED
Premier Financial Corp. Common Stock
PFC
| $616K | ﹤0.01% |
23,720
-5,752
| -20% | -$154K |
|
|
ZAGG
5190
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $615K | ﹤0.01% |
+33,328
| New | +$623K |
|
5191
Scorpio Tankers
STNG
$3.98B
| $614K | ﹤0.01% |
20,147
+9,522
| +90% | +$320K |
|
5192
PUT
Titan Machinery
TITN
$429M
| $614K | ﹤0.01% |
+29,000
| New | +$499K |
|
5193
First Trust Dividend Strength ETF
FTDS
$39.9M
| $613K | ﹤0.01% |
+18,323
| New | +$587K |
|
5194
PUT
Littelfuse
LFUS
$11.6B
| $613K | ﹤0.01% |
3,100
-4,100
| -57% | -$822K |
|
5195
PUT
New York Times
NYT
$10.4B
| $612K | ﹤0.01% |
33,100
+18,800
| +131% | +$349K |
|
5196
PUT
Arrow Electronics
ARW
$10.9B
| $611K | ﹤0.01% |
7,600
+1,800
| +31% | +$145K |
|
5197
PUT
Cars.com
CARS
$663M
| $611K | ﹤0.01% |
+21,200
| New | +$548K |
|
5198
PUT
Cheniere Energy
CQP
$33.4B
| $611K | ﹤0.01% |
20,600
-9,300
| -31% | -$262K |
|
5199
CALL
ProShares VIX Mid-Term Futures ETF
VIXM
$94.3M
| $611K | ﹤0.01% |
28,900
+2,000
| +7% | +$46.7K |
|
|
GNC
5200
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $611K | ﹤0.01% |
165,500
+31,000
| +23% | +$195K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.